George Perry to Hypoglycemic Agents
This is a "connection" page, showing publications George Perry has written about Hypoglycemic Agents.
Connection Strength
0.348
-
Associations of semaglutide with Alzheimer's disease-related dementias in patients with type 2 diabetes: A real-world target trial emulation study. J Alzheimers Dis. 2025 08; 106(4):1509-1522.
Score: 0.178
-
Associations of semaglutide with first-time diagnosis of Alzheimer's disease in patients with type 2 diabetes: Target trial emulation using nationwide real-world data in the US. Alzheimers Dement. 2024 12; 20(12):8661-8672.
Score: 0.170